SARS-CoV-2 Infection and Guillain-Barré Syndrome
Severe acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) is a beta-coronavirus that emerged as a global threat and caused a pandemic following its first outbreak in Wuhan, China, in late 2019. SARS-CoV-2 causes COVID-19, a disease ranging from relatively mild to severe illness. Older peop...
Main Authors: | Huda Makhluf, Henry Madany |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/8/936 |
Similar Items
-
Childhood Guillain–Barre syndrome in the SARS‐CoV‐2 era: Is there any causative relation?
by: Elham Pourbakhtyaran, et al.
Published: (2022-12-01) -
Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection: A Case Report
by: Mohammad Darvishi, et al.
Published: (2021-08-01) -
Disability evaluation in patients with Guillain-Barre syndrome and SARS-CoV-2 infection
by: Sofía S. Sanchez-Boluarte, et al.
Published: (2023-06-01) -
Guillain-Barré Syndrome in the COVID-19 Pandemic
by: Abdullah Ahmad Tawakul, et al.
Published: (2021-12-01) -
Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2
by: Char Leung
Published: (2021-09-01)